Volume | 559,826 |
|
|||||
News | - | ||||||
Day High | 25.82 | Low High |
|||||
Day Low | 24.74 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Avidity Biosciences Inc | RNA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
25.69 | 24.74 | 25.82 | 25.09 | 25.14 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
9,080 | 559,826 | $ 25.30 | $ 14,164,594 | - | 4.825 - 27.66 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:54:22 | 4 | $ 24.84 | USD |
Avidity Biosciences (RNA) Options Flow Summary
Avidity Biosciences Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
2B | 79.72M | - | 9.56M | -212.22M | -2.66 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Avidity Biosciences News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RNA Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 24.22 | 26.02 | 22.24 | 23.66 | 927,092 | 0.87 | 3.59% |
1 Month | 24.20 | 27.66 | 21.56 | 24.69 | 1,020,732 | 0.89 | 3.68% |
3 Months | 11.80 | 27.66 | 11.23 | 20.62 | 1,164,382 | 13.29 | 112.63% |
6 Months | 5.09 | 27.66 | 4.825 | 13.46 | 1,281,636 | 20.00 | 392.93% |
1 Year | 16.40 | 27.66 | 4.825 | 11.97 | 1,146,947 | 8.69 | 52.99% |
3 Years | 22.90 | 29.59 | 4.825 | 15.36 | 785,281 | 2.19 | 9.56% |
5 Years | 26.50 | 37.46 | 4.825 | 16.40 | 665,496 | -1.41 | -5.32% |
Avidity Biosciences Description
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease. |